These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8249670)

  • 1. Paroxystic neuropsychological symptoms as the early expression of hepatic encephalopathy. A case report.
    Abts H; Crols R; Mariën P; Saerens J; Holvoet J; de Deyn P
    Acta Neurol (Napoli); 1993 Aug; 15(4):268-76. PubMed ID: 8249670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of portal-systemic encephalopathy with slowly progressive, non-flapping tremor].
    Oue Y; Sakata C; Sudoh S; Kurokawa K; Nakamura S
    Rinsho Shinkeigaku; 1995 Aug; 35(8):889-92. PubMed ID: 8665732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric complications of hepatic failure.
    Sen S
    J Indian Med Assoc; 1968 Nov; 51(9):466-8. PubMed ID: 4891353
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic encephalopathy and reversible cortical blindness.
    Miyata Y; Motomura S; Tsuji Y; Koga S
    Am J Gastroenterol; 1988 Jul; 83(7):780-2. PubMed ID: 3381812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An autopsied case of type II citrullinemia--transient effectiveness with either citrate or benzoate to the consciousness disturbance].
    Ujihira N; Ohya M; Mabuchi C; Indo T; Hashizume Y
    Rinsho Shinkeigaku; 1989 Apr; 29(4):436-41. PubMed ID: 2692930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A; Hayashi S; Noguchi M
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological complications after coronary bypass grafting].
    Zoll A; Degirmenci U; Bleich S; Richter-Schmidinger T; Kornhuber J; Fischlein T; Weih M
    Fortschr Neurol Psychiatr; 2009 Feb; 77(2):97-101. PubMed ID: 19221972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].
    Eisenburg J
    Fortschr Med; 1996 Apr; 114(12):141-6. PubMed ID: 8682429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 56-year-old man with sudden onset of portosystemic encephalopathy years after severe electrocution trauma.
    Weiser KT; Suriawinata AA; van Leeuwen DJ
    Semin Liver Dis; 2008 Aug; 28(3):328-36. PubMed ID: 18814085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.
    Randolph C; Hilsabeck R; Kato A; Kharbanda P; Li YY; Mapelli D; Ravdin LD; Romero-Gomez M; Stracciari A; Weissenborn K;
    Liver Int; 2009 May; 29(5):629-35. PubMed ID: 19302444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic manifestations of hepatic disease.
    Rothstein JD; Herlong HF
    Neurol Clin; 1989 Aug; 7(3):563-78. PubMed ID: 2671636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.